Ident. | Authors (with country if any) | Title |
---|
002238 (2008) |
Stephen J. Kish [Canada, Niger] ; Junchao Tong [Canada] ; Oleh Hornykiewicz [Canada] ; Ali Rajput [Canada] ; Li-Jan Chang [Canada] ; Mark Guttman [Canada] ; Yoshiaki Furukawa [Canada] | Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease |
002329 (2008) |
Isabelle Boileau [Canada] ; Jerry J. Warsh [Canada] ; Mark Guttman [Canada] ; Jean A. Saint-Cyr [Canada] ; Tina Mccluskey [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Alan A. Wilson [Canada] ; Jeffrey H. Meyer [Canada] ; Stephen J. Kish [Canada] | Elevated serotonin transporter binding in depressed patients with Parkinson's disease: A preliminary PET study with [11C]DASB |
002737 (2006) |
Junchao Tong [Canada] ; Oleh Hornykiewicz ; Stephen J. Kish | Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline. |
002920 (2006) |
JUNCHAO TONG [Canada] ; Oleh Hornykiewicz [Autriche] ; Stephen J. Kish [Canada] | Inverse relationship between brain noradrenaline level and dopamine loss in parkinson disease : A possible neuroprotective role for noradrenaline |
002B99 (2004) |
Yoshiaki Furukawa [Canada] ; James J. Filiano ; Stephen J. Kish | Amantadine for levodopa-induced choreic dyskinesia in compound heterozygotes for GCH1 mutations. |
002C08 (2004) |
Anna Moszczynska ; Paul Fitzmaurice ; Lee Ang ; Kathryn S. Kalasinsky ; Gregory A. Schmunk ; Frank J. Peretti ; Sally S. Aiken ; Dennis J. Wickham [États-Unis] ; Stephen J. Kish | Why is parkinsonism not a feature of human methamphetamine users? |
002C84 (2004) |
Junchao Tong [Canada] ; Paul S. Fitzmaurice ; Lee Cyn Ang [Royaume-Uni] ; Yoshiaki Furukawa [Canada] ; Mark Guttman ; Stephen J. Kish | Brain dopamine‐stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy |
002D90 (2003) |
Mark Guttman [Canada] ; Stephen J. Kish ; Yoshiaki Furukawa | Current concepts in the diagnosis and management of Parkinson's disease. |
002E43 (2003) |
Paul S. Fitzmaurice [Canada] ; Lee Ang [Canada] ; Mark Guttman [Canada] ; Ali H. Rajput [Canada] ; Yoshiaki Furukawa [Canada] ; Stephen J. Kish [Canada] | Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease |
002F12 (2003) |
Sophie Vigouroux [France] ; Yoshiaki Furukawa [Canada] ; Luc Farout [France] ; Stephen J. Kish [Canada] ; Marièle Briand [France] ; Yves Briand [France] | Peptidase activities of the 20/26S proteasome and a novel protease in human brain |
002F50 (2003) |
Stephen J. Kish [Canada] | Biochemistry of Parkinson's disease: Is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease? |
003035 (2002) |
Yoshiaki Furukawa [Canada] ; Gregory Kapatos [États-Unis] ; John W. Haycock [États-Unis] ; Julian Worsley [Canada] ; Henry Wong [Canada] ; Stephen J. Kish [Canada] ; Torbjoern G. Nygaard [États-Unis] | Brain biopterin and tyrosine hydroxylase in asymptomatic dopa‐responsive dystonia |
003099 (2002) |
Yoshiaki Furukawa [Canada] ; Sophie Vigouroux [France] ; Henry Wong [Canada] ; Mark Guttman [Canada] ; Ali H. Rajput [Canada] ; LEE ANG [Canada] ; Marièle Briand [France] ; Stephen J. Kish [Canada] ; Yves Briand [France] | Brain proteasomal function in sporadic Parkinson's disease and related disorders |
003511 (2000) |
Yoshiaki Furukawa [Canada] ; Mark Guttman [Canada] ; Steven P. Sparagana [États-Unis] ; Joel M. Trugman [États-Unis] ; Keith Hyland [États-Unis] ; Philip Wyatt [Canada] ; Anthony E. Lang [Canada] ; Guy A. Rouleau [Canada] ; Mitsunobu Shimadzu [Japon] ; Stephen J. Kish [Canada] | Dopa‐responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene |
003978 (1998) |
Kelly Macmillan Muenter [États-Unis] ; Lysia S. Forno [États-Unis] ; Oleh Hornykiewicz [Autriche] ; Stephen J. Kish [Canada] ; Demetrius M. Maraganore [États-Unis] ; Richard J. Caselli [États-Unis] ; Haruo Okazaki [États-Unis] ; Frank M. Howard Jr. [États-Unis] ; Barry J. Snow [Nouvelle-Zélande] ; Donald B. Calne [Canada] | Hereditary form of parkinsonism—dementia |
003986 (1998) |
Yoshiaki Furukawa [Canada] ; Stephen J. Kish [Canada] ; E. Martina Bebin [États-Unis] ; Richard D. Jacobson [États-Unis] ; Julie S. Fryburg [États-Unis] ; Willam G. Wilson [États-Unis] ; Mitsunobu Shimadzu [Japon] ; Keith Hyland [États-Unis] ; Keith Trugman [États-Unis] | Dystonia with motor delay in compound heterozygotes for GTP‐cyclohydrolase I gene mutations |
003E41 (1996) |
Michel P. Furukawa [Japon, Canada] ; Mitsunobu Shimadzu [Japon] ; Ali H. Rajput [Canada] ; Yumiko Shimuzu [Japon] ; Tetsuzo Tagawa [Japon] ; Hideo Mori [Japon] ; Masayuki Yokochi [Japon] ; Hirotaro Narabayashi [Japon] ; Oleh Hornykiewicz [Autriche] ; Yoshikuni Mizuno [Japon] ; Stephen J. Kish [Canada] | GTP‐cyclohydrolase I gene mutations in hereditary progressive and dopa‐responsive dystonia |
004C30 (1988) |
Douglas S. Gilbert [Canada] ; Stephen J. Kish [Canada] ; Li-Jan Chang [Canada] ; Caryl Morito [Canada] ; Kathleen Shannak [Canada] ; Oleh Hornykiewicz [Canada, Autriche] | Dementia, parkinsonism, and motor neuron disease: Neurochemical and neuropathological correlates |
004D50 (1987) |
Thomas L. Perry [Canada] ; Voon Wee Yong [Canada] ; William J. Godolphin [Canada] ; Michelle Sutter [Canada] ; Shirley Hansen [Canada] ; Stephen J. Kish [Canada] ; James G. Foulks [Canada] ; Masatoshi Ito [Canada] | Inability to produce a model of dialysis encephalopathy in the rat by aluminum administration |
004F36 (1985) |
Stephen J. Kish [Canada] ; Caryl Morito [Canada] ; Oleh Hornykiewicz [Canada] | Glutathione peroxidase activity in Parkinson's disease brain |
004F53 (1985) |
Thomas L. Perry ; Voon Wee Yong ; Masatoshi Ito ; Karen Jones ; Richard A. Wall ; James G. Foulks ; James M. Wright ; Stephen J. Kish | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not destroy nigrostriatal neurons in the scorbutic guinea pig |